MeiraGTx Holdings Plc is a clinical-stage genetic medicines company with a broad pipeline of late-stage clinical programs, including Parkinson’s disease, radiation-induced xerostomia and AIPL1-associated retinal dystrophy. It targets local delivery of small doses of genetic medicines to treat both inherited and more common conditions with severe unmet needs. The company was founded on March 20, 2015 and is headquartered in New York, NY.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
403
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. MeiraGTx Holdings plc market cap is $779.89M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. MeiraGTx Holdings plc 52 week high is $15.35 as of November 22, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. MeiraGTx Holdings plc 52 week low is $6.62 as of November 22, 2026.
MeiraGTx Holdings plc stock price today is $7.98.
MeiraGTx Holdings plc stock price yesterday was $8.14.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. MeiraGTx Holdings plc's P/E ratio is 9.96.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. MeiraGTx Holdings plc P/B ratio is 3.6219.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. MeiraGTx Holdings plc 50-day moving average is $10.22.